Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence.
“For patients in need of cardiovascular or cardiothoracic imaging, the SpotLight Duo is the first cardiothoracic CT incorporating all of Arineta’s patient centric technologies. With one heartbeat, we can provide both high-temporal as well as iso-temporal resolution images that can be used for comprehensive cardiac and thoracic CT assessment,” said Doug Ryan, CEO of Arineta
Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence.
Explore how digital enhancement tools are revolutionizing medical imaging by improving the quality and clarity of visuals. Learn about the impact of these tools on diagnostic accuracy and the ethical considerations for their use in patient care.
“This partnership with Del Medical comes at an excellent time,” said Amol Karnick, President and CEO of KA Imaging. “After the pandemic, mobile imaging has become more prominent in many healthcare facilities, so offering a solution to improve the visualization of bones and tissues at the bedside is essential,” said Karnick.
The partnership seeks to contribute to driving healthcare transformation across Saudi Arabia, aligning with the Kingdom's 'Saudi Vision 2030' strategy.
"Partnering with Amstelland and providing them with Sectra One makes me proud. Our subscription model offers them the flexibility to scale their imaging solution, ensuring that they can continue to provide high-quality care to their patients while adapting to the changing healthcare landscape," says Peter Osinga, Managing Director, Sectra Benelux and DACH.
Techsomed's BioTrace platform, currently in advanced clinical evaluation, is a significant advancement in Image Guided Ablation Therapy. The technology leverages standard imaging—such as ultrasound (US) along with computed tomography (CT) or magnetic resonance imaging (MRI).
Jie Xue, President and CEO of MR at GE HealthCare. “Our latest PET/MR technology will directly impact the most challenging diseases, such as prostate cancer and Alzheimer's Disease. These diseases require precise and comprehensive imaging for accurate diagnosis, treatment planning, and therapy monitoring. We are excited to see SIGNA PET/MR AIR addressing these challenges and fulfilling our vision of providing access to advanced, personalized care.”
“Combining our expertise in noninvasive monitoring and signal processing technologies with Philips’ expertise in integrated patient monitoring and therapy solutions is a win-win for patients and clinicians alike," said Jon Coleman, President of Worldwide OEM Sales and Global Health, Masimo. "We are proud that Philips has chosen to make our innovative SedLine, O3, and NomoLine technologies available to their customers. We look forward to continuing our partnership with a focus on improving patient outcomes and reducing the cost of care.”
By using this website you agree to accept Medical Device News Magazine Privacy Policy
